Ajooni Biotech Limited — Capital/Financing Update 2021

Aug 2, 2021

ONI BIOTECH LIMITE

Regd. Office: D-118, Industrial Area, Phase-VII, Mohali-160055 (Pb.) Phone: 0172-5020758-69 Website: www.ajoonibiotech.com E-mail: ajooni.biotech@gmail.com / info@ajoonibiotech.com CIN: L85190PB2010PLC040162

Date: 02/08/2021

To. National Stock Exchange of India Ltd Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex, Bandra (E) Mumbai - 400051

Dear Sir / Madam,

Subject: Outcome of the Board Meeting held on August 02, 2021, Monday, pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015.

SYMBOL: AJOONI

Dear Sir/Madam,

With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held on Monday, August 02, 2021 at 11.30 a.m concluded at 01.40 p.m. Following transactions were considered and approved:

• 1. Un-Audited Financial Results for the quarter ended on 30th June 2021.
• 1. The Board has considered and approved the offer and issue of fully paid-up equity shares of the Company, on a rights issue to existing eligible equity shareholders of the Company as at the record date for an amount not exceeding Rs. 30.00 Crore, in accordance with applicable laws, including the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 (the "Rights Issue").

For the purposes of giving effect to the Rights Issue, the Board has constituted and authorized the Right Issue Committee to decide the terms and conditions of the Rights Issue, including the instrument, issue price, rights entitlement ratio, record date, timing of the Rights Issue and other related matters.

You are requested to kindly take the same on your record and acknowledge receipt.

Thanking You, Yours Truly. For Ajooni Biotech Limited MOHAL¹ Jasjot Singh Managing Director DIN: 01937631